首页> 美国卫生研究院文献>other >Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system
【2h】

Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system

机译:使用99mTc标记的单阳离子试剂和高分辨率固定SPECT系统对人乳腺肿瘤中的多药耐药性进行成像识别

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Imaging recognition of multidrug-resistance by 99mTc-labeled sestamibi, tetrofosmin and furifosmin in mice bearing human breast tumors was evaluated using a high-resolution SPECT, FASTSPECT. Imaging results showed that the washout rates in drug-resistant MCF7/D40 tumors were significantly greater than that in drug-sensitive MCF7/S tumors. Furifosmin exhibited greater washout from both MCF7/S and MCF7/D40 than sestamibi, while tetrofosmin washout was greater than sestamibi in MCF7/D40 only. Feasibility of the monocationic agents for characterizing MDR expression was well clarified with FASTSPECT imaging.
机译:使用高分辨率SPECT,FASTSPECT评价了 99m Tc标记的司他达比,替曲磷和呋喃他明对携带人乳腺肿瘤的小鼠的多药耐药性的成像识别。成像结果显示,耐药性MCF7 / D40肿瘤的清除率明显高于药物敏感性MCF7 / S肿瘤。福瑞福明对MCF7 / S和MCF7 / D40的清除率均比司他米比大,而替福福明的清除率仅比司他米比大。用FASTSPECT成像可以很好地阐明用于表征MDR表达的单阳离子试剂的可行性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号